BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Teneligliptin
1
Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies
11/18/2024 3:30:39 AM | Browse: 220 | Download: 704
2
Potential mechanism of teneligliptin in the treatment of diabetic cardiomyopathy
9/26/2024 8:51:01 AM | Browse: 281 | Download: 914
3
Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy?
8/27/2024 3:11:19 PM | Browse: 280 | Download: 887
4
Teneligliptin: A potential therapeutic approach for diabetic cardiomyopathy
7/26/2024 6:56:09 AM | Browse: 233 | Download: 920
5
Diabetic cardiomyopathy: Emerging therapeutic options
7/26/2024 6:56:09 AM | Browse: 303 | Download: 680
6
Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome
4/12/2024 1:04:39 AM | Browse: 186 | Download: 1465
7
Drug interactions of dipeptidyl peptidase 4 inhibitors involving CYP enzymes and P-gp efflux pump
4/30/2019 3:02:03 AM | Browse: 1291 | Download: 1854
8
Dipeptidyl peptidase-4: A key player in chronic liver disease
9/16/2014 1:19:00 PM | Browse: 1655 | Download: 1815